United Kingdom · Question · Written question
HL HL2342
Advanced Therapy Medicinal Products
Introduced
8 February 2024
Last action
21 February 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 February 2024
Summary
To ask His Majesty's Government what steps they are taking to enhance the safety, quality, supply and accessibility of therapies derived from substances of human origin.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 February 2024
Written question
To ask His Majesty's Government what steps they are taking to enhance the safety, quality, supply and accessibility of therapies derived from substances of human origin.
Source: Lords
21 February 2024
Answer
Therapies derived from substances of human origin include those using reproductive and non-reproductive tissues and cells, organs, stem cells, blood, and blood products including plasma. A range of different bodies have responsibility for safety, quality,...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-02-08/HL2342
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1688736
- uk · wq-1688736 · source updated 21 February 2024